Loading...
XKRX096760
Market cap147mUSD
Jan 06, Last price  
3,055.00KRW
1D
0.99%
1Q
-1.13%
Jan 2017
-65.60%
IPO
-12.14%
Name

JW Holdings Corp

Chart & Performance

D1W1MN
XKRX:096760 chart
P/E
11.36
P/S
0.23
EPS
269.01
Div Yield, %
8.21%
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
5.05%
Revenues
928.07b
+7.35%
237,690,310,000529,239,679,000556,675,690,000554,239,674,230516,012,168,270511,945,579,900530,262,876,270573,920,210,970622,617,304,970680,479,987,980683,718,165,770725,365,869,060726,423,996,270781,514,840,000788,936,980,900864,536,430,720928,071,670,920
Net income
19.03b
-59.07%
-7,232,724,000-5,165,882,0001,040,783,000-11,563,027,000-32,112,262,000-22,032,155,92017,817,457,410-8,987,986,000181,412,000-8,663,432,00054,021,815,78023,169,194,370-31,636,720,3803,385,179,0004,434,634,09046,482,142,07019,026,282,330
CFO
112.32b
+7.56%
16,241,967,0008,284,997,000-6,940,143,000-1,615,130,760-3,887,889,710861,853,070-54,030,353,410-17,175,940,050-23,975,359,150-29,214,390,35010,511,742,250195,762,386,11098,682,527,140108,622,768,000109,644,020,380104,426,313,770112,317,545,770
Dividend
Dec 27, 2023105 KRW/sh
Earnings
Feb 03, 2025

Profile

JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.
URL
http://www.jw-holdings.co.kr
IPO date
Jul 31, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
928,071,671
7.35%
864,536,431
9.58%
Cost of revenue
666,264,383
634,755,803
Unusual Expense (Income)
NOPBT
261,807,288
229,780,628
NOPBT Margin
28.21%
26.58%
Operating Taxes
22,364,300
24,512,611
Tax Rate
8.54%
10.67%
NOPAT
239,442,988
205,268,017
Net income
19,026,282
-59.07%
46,482,142
948.16%
Dividends
(17,740,905)
(15,419,363)
Dividend yield
7.23%
7.52%
Proceeds from repurchase of equity
(306,668)
(334,053)
BB yield
0.12%
0.16%
Debt
Debt current
512,103,645
478,414,325
Long-term debt
68,939,343
82,132,249
Deferred revenue
614,534
1,118,056
Other long-term liabilities
39,982,961
15,507,882
Net debt
335,472,066
435,219,374
Cash flow
Cash from operating activities
112,317,546
104,426,314
CAPEX
(71,080,237)
(70,109,135)
Cash from investing activities
(69,227,277)
(107,019,727)
Cash from financing activities
(29,077,610)
16,820,245
FCF
157,417,380
180,539,101
Balance
Cash
154,743,079
162,938,222
Long term investments
90,827,843
(37,611,022)
Excess cash
199,167,338
82,100,379
Stockholders' equity
285,854,971
286,301,218
Invested Capital
744,770,837
797,755,752
ROIC
31.05%
27.05%
ROCE
27.27%
25.62%
EV
Common stock shares outstanding
70,297
72,263
Price
3,490.00
23.04%
2,836.47
-13.12%
Market cap
245,336,286
19.69%
204,970,782
-11.14%
EV
805,598,512
871,763,186
EBITDA
306,029,254
269,906,542
EV/EBITDA
2.63
3.23
Interest
32,531,927
25,289,592
Interest/NOPBT
12.43%
11.01%